Why Attend the Innovation in Obesity Therapeutics Summit?
Building on a surge in clinical trial results, including Novo Nordisk's Amycretin with late-stage trials showing a 22% weight loss in Phase 2, the obesity therapeutic landscape is delving into more wide-ranging target approaches alongside these highly well-known therapeutics. This Summit will dissect the future of obesity drug discovery, development, and clinical application beyond GLP-1s.
This is your opportunity to be at the forefront of obesity drug development as the therapeutic potential for metabolic health expands, accelerating the development of life-changing treatments for millions affected globally.
What to Expect?
Propel Your Drug Development Programs Forward
Propel your drug development programs forward by exploring novel targets and mechanisms, with the advantage of exploring the latest research and preclinical insights to drive the next generation of obesity therapeutics
Ensure Long-Term Treatment Engagement
Ensure long-term treatment engagement and patient comfort using muscle-preserving and tolerability-driven approaches into your development programs, with the advantage of designing therapies that enhance patient safety
Accelerate Patient-Focussed Innovation
Accelerate patient-focussed innovation by bridging the gap between preclinical discovery and clinical success, with the advantage of evaluating innovative therapeutic modalities and administration systems that bring more effective treatments to market faster
Join Your Peers to
Uncover the Next Generation of Obesity Therapeutics
Uncover the next generation of obesity therapeutics by exploring novel targets and mechanisms beyond GLP-1s, leveraging cutting-edge research in adipose tissue biology and controlled metabolic accelerators to drive profound and sustained weight loss
Redefine Success in Obesity Care
Redefine success in obesity care by moving beyond the scale and focusing on a higher quality of weight loss, learning how to leverage muscle-preserving therapies and new body composition readouts to elevate metabolic health
Elevate Patient Experience
Elevate patient experience and adherence by exploring cutting-edge solutions for improved tolerability and flexible dosing regimens, ensuring long-term treatment engagement that is both effective and patient-centric
Accelerate the Pipeline from Bench to Bedside
Accelerate the pipeline from bench to bedside by bridging the gap between preclinical discovery and clinical success through the analysis of innovative therapeutic modalities, from long-acting antibodies to oral formulations
Harness the Power of Synergy
Harness the power of synergy by discovering how to combine multiple therapeutic pathways with multi-agonist therapies and combination regimens to achieve greater efficacy and tackle the challenges of tolerability, muscle loss and administration routes for obesity
Who You Could Have Met?
The 2nd Innovation in Obesity Therapeutics Summit is the definitive meeting for 60+ senior leaders across biopharma, innovative biotech, and academia. The audience includes pioneering scientists in metabolic disease, drug discovery, and clinical development experts. This is your exclusive opportunity to gain unparalleled insights from a diverse roster of 18+ renowned speakers and connect with key decision-makers from leading companies in obesity therapeutics, such as Eli Lilly, Boehringer Ingelheim, Supercede Therapeutics and Veru who are shaping the future of innovative obesity treatments.
Seniority of Attendees
Types of Companies Attending
Explore the 2025 Full Event Guide
- Get a full overview of the agenda, speakers, and session topics in one place
- Preview featured case studies that we’ll be shining a light on throughout the event
- Discover exclusive content such as keynote highlights, attendee benefits and more
- Share easily with colleagues or decision-makers to assess and mobilize interest
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.